Pre-trabeculectomy intravitreal injections of Bevacizumab for treating neovascular glaucoma in diabetic patients
Background/Aim. Neovascular glaucoma (NVG) is a secondary glaucoma caused by occlusion of the trabecular network of newly formed blood vessels. The aim of this study was to evaluate the efficacy and safety of intravitreal injections of bevacizumab before trabeculectomy with mitomycin C (MMC) for the...
Main Authors: | Marjanović Ivan, Marjanović Marjan, Gvozdenović Ranko, Marjanović Marija, Marković Vujica, Božić Marija, Marić Vesna, Martinez Antonio |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2020-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800137M.pdf |
Similar Items
-
Observation of Bevacizumab intravitreal injection combined with compound trabeculectomy for NVG
by: Bing Wu, et al.
Published: (2018-07-01) -
Clinical observation of trabeculectomy with mitomycin and interferon therapy on neovascular glaucoma
by: Dao-Hong Wan, et al.
Published: (2015-01-01) -
Intravitreal Bevacizumab injection combined duplex technique in treatment of neovascular glaucoma
by: Zheng-Jun Hu, et al.
Published: (2015-05-01) -
Effect factors of trabeculectomy with intraoperative application of mitomycin C for neovascular glaucoma
by: Yun-Xing Chang, et al.
Published: (2016-07-01) -
Trabeculectomy combined with mitomycin and retinal condensation for neovascular glaucoma
by: Yue-Sheng Qiu, et al.
Published: (2016-04-01)